Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Amazon
AMZN
|
+$732M |
| 2 |
Meta Platforms (Facebook)
META
|
+$360M |
| 3 |
Tesla
TSLA
|
+$315M |
| 4 |
Roblox
RBLX
|
+$302M |
| 5 |
Sea Limited
SE
|
+$277M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$407M |
| 2 |
Snowflake
SNOW
|
+$365M |
| 3 |
Visa
V
|
+$328M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 5 |
Micron Technology
MU
|
+$263M |
Sector Composition
| 1 | Technology | 21.92% |
| 2 | Healthcare | 13.04% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 10% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
3426
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $183K | ﹤0.01% |
29,958
-938
| -3% | -$5.73K |
|
3427
Aviat Networks
AVNW
$305M
| $182K | ﹤0.01% |
5,547
-213
| -4% | -$6.99K |
|
3428
Lineage Cell Therapeutics
LCTX
$306M
| $182K | ﹤0.01% |
72,135
+143
| +0.2% | +$361 |
|
3429
Pulse Biosciences
PLSE
$977M
| $182K | ﹤0.01% |
8,408
-263
| -3% | -$5.69K |
|
|
CTO
3430
CTO Realty Growth
CTO
$544M
| $181K | ﹤0.01% |
10,086
-1,308
| -11% | -$23.5K |
|
3431
Galicia Financial Group
GGAL
$4.81B
| $181K | ﹤0.01% |
18,014
+9,725
| +117% | +$97.7K |
|
|
IMDX
3432
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$88.1M
| $181K | ﹤0.01% |
2,540
+255
| +11% | +$18.2K |
|
3433
Seneca Foods Class A
SENEA
$751M
| $180K | ﹤0.01% |
3,737
-194
| -5% | -$9.34K |
|
3434
Cogent Biosciences
COGT
$1.77B
| $180K | ﹤0.01% |
21,373
-687
| -3% | -$5.79K |
|
3435
MeridianLink
MLNK
$1.47B
| $180K | ﹤0.01% |
+8,049
| New | +$180K |
|
3436
DURECT Corp
DRRX
| $179K | ﹤0.01% |
13,944
-595
| -4% | -$7.64K |
|
|
HGEN
3437
DELISTED
HUMANIGEN, INC.
HGEN
| $179K | ﹤0.01% |
30,226
-503
| -2% | -$2.98K |
|
3438
Citizens
CIA
$274M
| $178K | ﹤0.01% |
28,715
-2,483
| -8% | -$15.4K |
|
3439
Janux Therapeutics
JANX
$1.45B
| $178K | ﹤0.01% |
+8,185
| New | +$178K |
|
|
STXB
3440
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $178K | ﹤0.01% |
7,381
-231
| -3% | -$5.57K |
|
3441
Lantronix
LTRX
$174M
| $177K | ﹤0.01% |
30,416
+30,412
| +760,300% | +$177K |
|
|
ODT
3442
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $177K | ﹤0.01% |
60,901
-142,062
| -70% | -$413K |
|
|
FXLV
3443
DELISTED
F45 Training Holdings Inc.
FXLV
| $176K | ﹤0.01% |
+11,796
| New | +$176K |
|
3444
EverCommerce
EVCM
$2.15B
| $176K | ﹤0.01% |
+10,642
| New | +$176K |
|
3445
Vor Biopharma
VOR
$220M
| $176K | ﹤0.01% |
11,233
+3,954
| +54% | +$62K |
|
|
NAGE
3446
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $176K | ﹤0.01% |
28,041
-866
| -3% | -$5.44K |
|
3447
Blue Ridge Bankshares
BRBS
$380M
| $175K | ﹤0.01% |
9,973
-326
| -3% | -$5.72K |
|
3448
Vanguard Real Estate ETF
VNQ
$34.8B
| $175K | ﹤0.01% |
1,720
| – | – |
|
3449
Harvard Bioscience
HBIO
$19.7M
| $174K | ﹤0.01% |
24,931
+1,992
| +9% | +$13.9K |
|
|
SBOW
3450
DELISTED
SilverBow Resources, Inc.
SBOW
| $174K | ﹤0.01% |
+7,106
| New | +$174K |
|